Research Progress on Gene Mutation and CHIP in Pathogenesis of MDS --Review.
10.19746/j.cnki.issn.1009-2137.2023.03.043
- Author:
Miao HE
1
;
Tao WU
2
Author Information
1. Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, Gansu Province, China.
2. Department of Hematology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou 730050, Gansu Province, China.E-mail: wutaozhen@yeah.net.
- Publication Type:Review
- Keywords:
clonal hematopoiesis of indeterminate potential;
gene mutations;
myelodysplastic syndromes;
pathogenesis
- MeSH:
Aged;
Humans;
DNA Methylation;
Mutation;
Myelodysplastic Syndromes/pathology*;
Prognosis;
Signal Transduction
- From:
Journal of Experimental Hematology
2023;31(3):907-910
- CountryChina
- Language:Chinese
-
Abstract:
With the development of molecular biology techniques, the people's understanding of myelodysplastic syndromes (MDS) has greatly improved, a heterogeneous hematopoietic pre-malignant disorder of the stem cells. Gene mutations include RNA splicing, DNA methylation, chromosome modification, transcription factors, signal transduction kinases, RAS pathways, cohesion complexes, DNA repair, etc. Gene mutation is the determinant of diagnostic typing and therapeutic efficacy of MDS. The new concepts of CHIP and ICUS have aroused people's attention to the elderly patients with clonal hematopoiesis and non-clonal cytopenia but without MDS characteristics, who have the possibility of high-risk transformation to MDS and leukemia. In order to better understand the pathogenesis of MDS, the significance of gene mutations, CHIP and ICUS in the diagnosis and prognosis of MDS were reviewed in this paper.
